Wasatch Advisors Inc Athira Pharma, Inc. Transaction History
Wasatch Advisors Inc
- $18.5 Billion
- Q2 2024
A detailed history of Wasatch Advisors Inc transactions in Athira Pharma, Inc. stock. As of the latest transaction made, Wasatch Advisors Inc holds 1,296,128 shares of ATHA stock, worth $790,638. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,296,128Holding current value
$790,638% of portfolio
0.02%Shares
7 transactions
Others Institutions Holding ATHA
# of Institutions
75Shares Held
23.1MCall Options Held
73.4KPut Options Held
97.8K-
Perceptive Advisors LLC New York, NY5.4MShares$3.3 Million0.41% of portfolio
-
Baker Bros. Advisors LP New York, NY3.15MShares$1.92 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.63MShares$997,0040.0% of portfolio
-
Propel Bio Management, LLC Los Angeles, CA1.49MShares$910,6032.57% of portfolio
-
Simplify Asset Management Inc. New York, NY1.49MShares$910,6030.29% of portfolio
About Athira Pharma, Inc.
- Ticker ATHA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,817,700
- Market Cap $23.1M
- Description
- Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...